Overview

Editas Medicine, Inc. is a leading genome editing company focused on translating the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 technologies into a robust pipeline of medicines aimed at treating a broad range of serious diseases. The company is dedicated to harnessing the potential of these transformative technologies to develop medicines in the therapeutic areas of oncology, ophthalmology, and more.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Editas Medicine, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Editas Medicine, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.